• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏儿科药物制剂。

Lack of pediatric drug formulations.

作者信息

Nahata M C

机构信息

Department of Pharmacy and Pediatrics, Ohio State University and Children's Hospital, Columbus, Ohio 43210-1291, USA.

出版信息

Pediatrics. 1999 Sep;104(3 Pt 2):607-9.

PMID:10469800
Abstract

Many drugs frequently used in infants and young children are not available in suitable dosage forms. Liquid dosage forms must be prepared extemporaneously, while using appropriate excipients. However, it is critical to determine the stability of various drugs at clinically important concentrations and practical storage conditions. It is of concern that few funding agencies are willing to support research on the development of stable liquid dosage forms for pediatric patients. The need for such data will continue, because it is unlikely that all drugs approved for adults will also be labeled simultaneously for potential use in infants and children. Presentations and publications on stable drug formulations will offer the opportunities for pediatric patients to receive the desired drugs and doses most effectively and safely.

摘要

许多常用于婴幼儿的药物没有合适的剂型。必须临时配制液体制剂,并使用适当的辅料。然而,确定各种药物在临床重要浓度和实际储存条件下的稳定性至关重要。令人担忧的是,很少有资助机构愿意支持针对儿科患者稳定液体制剂开发的研究。对这类数据的需求将持续存在,因为不太可能所有已批准用于成人的药物会同时标注可用于婴幼儿。关于稳定药物制剂的报告和出版物将为儿科患者提供机会,使其最有效、最安全地获得所需药物和剂量。

相似文献

1
Lack of pediatric drug formulations.缺乏儿科药物制剂。
Pediatrics. 1999 Sep;104(3 Pt 2):607-9.
2
Extemporaneous drug formulations.临时调配的药物制剂。
Clin Ther. 2008 Nov;30(11):2112-9. doi: 10.1016/j.clinthera.2008.11.020.
3
Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.由市售产品临时配制的液体制剂的稳定性考量。
J Pharm Pharm Sci. 2006;9(3):398-426.
4
The economics of pediatric formulation development for off-patent drugs.非专利儿科药物制剂研发的经济学
Clin Ther. 2008 Nov;30(11):2133-45. doi: 10.1016/j.clinthera.2008.11.019.
5
The position of the pharmaceutical industry in the development of drugs for pediatric use.制药行业在儿科用药研发中的地位。
Pediatr Pharmacol (New York). 1980;1(1):15-9.
6
Changing requirements for evaluation of pharmacologic agents.药物评估要求的不断变化。
Pediatrics. 2004 Apr;113(4 Suppl):1128-32.
7
Pediatric drug formulations: challenges and potential solutions.儿科药物制剂:挑战与潜在解决方案
Ann Pharmacother. 1999 Feb;33(2):247-9. doi: 10.1345/aph.18154.
8
[Are children getting the right drugs?].孩子们用对药了吗?
Tidsskr Nor Laegeforen. 2005 Dec 1;125(23):3290-2.
9
Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.尤尼斯·肯尼迪·施莱佛国立儿童健康与人类发展研究所儿科制剂倡议:第二届儿科制剂研讨会会议记录。
Clin Ther. 2012 Nov;34(11):S1-10. doi: 10.1016/j.clinthera.2012.09.013.
10
Criteria supporting the study of drugs in the newborn.支持新生儿药物研究的标准。
Clin Ther. 2006 Sep;28(9):1385-98. doi: 10.1016/j.clinthera.2006.09.007.

引用本文的文献

1
Pediatric Formulations Developed by Extrusion-Based 3D Printing: From Past Discoveries to Future Prospects.基于挤出式3D打印技术开发的儿科制剂:从过去的发现到未来的前景
Pharmaceutics. 2024 Mar 22;16(4):441. doi: 10.3390/pharmaceutics16040441.
2
Manipulated Oral and Rectal Drugs in a Paediatric Swedish University Hospital, a Registry-Based Study Comparing Two Study-Years, Ten Years Apart.瑞典一家大学儿童医院的口服和直肠给药情况:一项基于登记系统的研究,比较相隔十年的两个研究年份。
Pharmaceuticals (Basel). 2022 Dec 21;16(1):8. doi: 10.3390/ph16010008.
3
Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms.
使用未标注或未获许可的口服剂型给儿童用药的剂量准确性。
Pharmaceutics. 2021 Jul 2;13(7):1014. doi: 10.3390/pharmaceutics13071014.
4
Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension.氨氯地平/缬沙坦混悬液的临时调配与生理模型构建
Int J Hypertens. 2021 Mar 12;2021:6695744. doi: 10.1155/2021/6695744. eCollection 2021.
5
Advances in Oral Drug Delivery.口服给药递送的进展
Front Pharmacol. 2021 Feb 19;12:618411. doi: 10.3389/fphar.2021.618411. eCollection 2021.
6
Evaluating Solubility of Celecoxib in Age-Appropriate Fasted- and Fed-State Gastric and Intestinal Biorelevant Media Representative of Adult and Pediatric Patients: Implications on Future Pediatric Biopharmaceutical Classification System.评估塞来昔布在适合成人和儿科患者年龄的禁食和进食状态下胃和肠道生物相关介质中的溶解度:对未来儿科生物药剂学分类系统的影响。
AAPS PharmSciTech. 2021 Mar 1;22(3):84. doi: 10.1208/s12249-021-01958-3.
7
Adjusting the dose in paediatric care: dispersing four different aspirin tablets and taking a proportion.调整儿科用药剂量:分散四片不同剂量的阿司匹林片剂并按比例服用。
Eur J Hosp Pharm. 2021 Mar;28(2):76-82. doi: 10.1136/ejhpharm-2019-001903. Epub 2019 Jun 11.
8
Comparing Two Methods of Tablet Manipulation to Adjust the Warfarin Dose in Paediatric Care.比较两种片剂处理方法以调整儿科护理中华法林的剂量
Pharmaceutics. 2020 Apr 18;12(4):375. doi: 10.3390/pharmaceutics12040375.
9
Adjusting the dose in paediatric care by dispersing fragments of four different aspirin tablets.调整儿科护理中剂量的方法是分散四片不同阿司匹林片剂的碎片。
Acta Paediatr. 2020 Nov;109(11):2394-2401. doi: 10.1111/apa.15216. Epub 2020 Feb 22.
10
Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development.儿童和青年成人剂型偏好咨询研究:为以患者为中心和基于患者信息的剂型开发铺平道路。
Eur J Hosp Pharm. 2017 Nov;24(6):332-337. doi: 10.1136/ejhpharm-2016-001023. Epub 2016 Sep 2.